Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome.
AffiliationCRC Section of Molecular Genetics, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractWe have analysed Li-Fraumeni syndrome families, previously shown to be negative for mutations in TP53, for mutations to the tumour suppressor genes PTEN and CDKN2. These genes function in cell cycle progression or are mutated in a variety of tumours. We have detected no mutations in the family members tested.
CitationExclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome. 1999, 80 (1-2):9-10 Br. J. Cancer
JournalBritish Journal of Cancer
- Microsatellite instability, PTEN and p53 germline mutations in glioma families.
- Authors: Malmer B, Grönberg H, Andersson U, Jonsson BA, Henriksson R
- Issue date: 2001
- Identification of a novel PTEN intronic deletion in Li-Fraumeni syndrome and its effect on RNA processing.
- Authors: Brown LT, Sexsmith E, Malkin D
- Issue date: 2000 Nov
- Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
- Authors: Zhou XP, Sanson M, Hoang-Xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre JY, Thomas G, Hamelin R
- Issue date: 1999 Dec
- Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
- Authors: MacGeoch C, Turner G, Bobrow LG, Barnes DM, Bishop DT, Spurr NK
- Issue date: 1995 Mar
- Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
- Authors: Bougeard G, Limacher JM, Martin C, Charbonnier F, Killian A, Delattre O, Longy M, Jonveaux P, Fricker JP, Stoppa-Lyonnet D, Flaman JM, Frébourg T
- Issue date: 2001 Apr